The Prevalence of Dysphonia and Dysphagia Symptoms in Patients on Statin Therapy

Simple item page
dc.contributor.authorHamdan, Abdul Latif H.
dc.contributor.authorKhalifee, Elie
dc.contributor.authorAl Souky, Nader
dc.contributor.authorSaridar, Bakr
dc.contributor.authorAbi-Akl, Pierre Richard
dc.contributor.authorAzar, Sami T.
dc.contributor.departmentOtolaryngology/Head and Neck Surgery
dc.contributor.departmentInternal Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:09:28Z
dc.date.available2025-01-24T12:09:28Z
dc.date.issued2020
dc.description.abstractObjective: To investigate the effect of statin therapy on swallowing and phonation. Methods: A group of patients on statin therapy and another group not on statins (controls) presenting to the endocrinology clinic between January 2018 and April 2018 were asked to participate. All patients filled Voice Handicap Index (VHI-10), Eating Assessment Tool (EAT-10), and Likert scales for vocal fatigue and hoarseness. Demographic data included age, gender, allergy, and history of smoking. Results: A total of 160 patients were recruited, 75 patients on statin therapy and 85 not on statin therapy. The mean age of the study group was 55.00 years, whereas that of the control group was 45.70 years. The mean duration of statin treatment was 74.92 months. The mean VHI-10 and EAT-10 scores were significantly higher in the statin group compared to the control group (P < 0.05). Although there was no significant difference in the mean Likert scale for vocal fatigue, the mean Likert scale for hoarseness was significantly higher in the statin group compared to the control group (P < 0.05). Conclusion: This investigation revealed a significantly higher prevalence of laryngopharyngeal symptoms in patients on statin therapy versus a control group. © 2019 The Voice Foundation
dc.identifier.doihttps://doi.org/10.1016/j.jvoice.2019.06.012
dc.identifier.eid2-s2.0-85069810348
dc.identifier.pmid31375400
dc.identifier.urihttp://hdl.handle.net/10938/32066
dc.language.isoen
dc.publisherMosby Inc.
dc.relation.ispartofJournal of Voice
dc.sourceScopus
dc.subjectDysphagia
dc.subjectDysphonia
dc.subjectEat-10
dc.subjectStatin therapy
dc.subjectVhi-10
dc.subjectDeglutition disorders
dc.subjectHoarseness
dc.subjectHumans
dc.subjectHydroxymethylglutaryl-coa reductase inhibitors
dc.subjectMiddle aged
dc.subjectPrevalence
dc.subjectHydroxymethylglutaryl coenzyme a reductase inhibitor
dc.subjectAdult
dc.subjectAllergy
dc.subjectArticle
dc.subjectCohort analysis
dc.subjectControlled study
dc.subjectDemography
dc.subjectEating assessment tool
dc.subjectEating disorder assessment
dc.subjectFatigue
dc.subjectFemale
dc.subjectGroups by age
dc.subjectHuman
dc.subjectLikert scale
dc.subjectMajor clinical study
dc.subjectMale
dc.subjectMedical history
dc.subjectPhonation
dc.subjectProspective study
dc.subjectQuestionnaire
dc.subjectSelf report
dc.subjectSmoking
dc.subjectSpeech and language assessment
dc.subjectSwallowing
dc.subjectTreatment duration
dc.subjectVoice handicap index
dc.titleThe Prevalence of Dysphonia and Dysphagia Symptoms in Patients on Statin Therapy
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2020-3062.pdf
Size:
94.67 KB
Format:
Adobe Portable Document Format
Download

Collections

Otolaryngology/Head and Neck Surgery
Internal Medicine